Access 2.8M+ Filings Sign Up Free
Galapagos NV Logo

Galapagos NV | GLPG - Profile, Filings, Stock Info & Investor Relations Data

Galapagos NV | GLPG
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Belgium
Founded
1999
Galapagos NV (GLPG)

Company Profile

Website
Investor Relations

About Galapagos NV

We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

Market Presence

Worldwide

Headquarters

Industriepark Mechelen Noord, Generaal De Wittelaan L11 A3
2800, Mechelen
Belgium

Company Video

Video thumbnail
Click to load video from YouTube

Galapagos NV (GLPG)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Galapagos NV (GLPG)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Contamine Jérôme (Board)
Buy EUR 30,800.87 EUR 26.60 10.01.25
↑
Guenter Peter (Board)
Buy EUR 24,603.46 EUR 26.60 10.01.25
↑
Svanberg Elisabeth (Board)
Buy EUR 24,348.15 EUR 26.61 10.01.25
↑
Huston Thad (Board)
Buy EUR 0.00 EUR 0.00 03.07.24
↑
Stoffels IMC (Board)
Buy EUR 0.00 EUR 0.00 17.05.24
◆
Stoffels IMC (Board)
Other EUR 1,428,334.05 EUR 28.05 01.05.24
◆
Missotten Annelies (Board)
Other EUR 373,990.65 EUR 28.05 01.05.24
◆
Cnossen Valeria (Board)
Other EUR 368,885.55 EUR 28.05 01.05.24
◆
Huston Thad (Board)
Other EUR 354,439.80 EUR 28.05 01.05.24
◆
GILEAD THERAPEUTICS A1 UNLIMITED COMPANY (Close relation)
Other EUR 0.00 EUR 0.00 30.04.24

Galapagos NV (GLPG)
Stock & Investor Information

ISINs

BE0003818359

LEI

549300QKJ78IY0IOV655

Stock Exchange Listings

Euronext Brussels

Stock Index Memberships

BEL20

Primary Stock Exchange Listing

View Galapagos NV on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology